MENU
+Compare
COLL
Stock ticker: NASDAQ
AS OF
Dec 26, 12:03 PM (EDT)
Price
$49.76
Change
+$0.18 (+0.36%)
Capitalization
1.57B

COLL Collegium Pharmaceutical Forecast, Technical & Fundamental Analysis

Collegium Pharmaceutical Inc is a specialty pharmaceutical company... Show more

COLL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for COLL with price predictions
Dec 24, 2025

COLL sees MACD Histogram just turned negative

COLL saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 01, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 37 instances where the indicator turned negative. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COLL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on COLL as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where COLL advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 222 cases where COLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. COLL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.705) is normal, around the industry mean (24.266). P/E Ratio (30.417) is within average values for comparable stocks, (74.353). COLL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.954). COLL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.597) is also within normal values, averaging (64.216).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
COLL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

COLL is expected to report earnings to fall 4.44% to $2.15 per share on February 19

Collegium Pharmaceutical COLL Stock Earnings Reports
Q4'25
Est.
$2.15
Q3'25
Beat
by $0.37
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.09
The last earnings report on November 06 showed earnings per share of $2.25, beating the estimate of $1.88. With 199.01K shares outstanding, the current market capitalization sits at 1.57B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Technology Center Drive
Phone
+1 781 713-3699
Employees
197
Web
https://www.collegiumpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISTAX25.980.12
+0.46%
ICON Equity Investor
PSLCX10.300.03
+0.29%
Putnam Small Cap Value C
JCMVX28.260.07
+0.25%
JPMorgan Mid Cap Value C
PGPRX27.010.06
+0.22%
George Putnam Balanced R
NBFAX33.800.03
+0.09%
Neuberger Focus Adv

COLL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with AMPH. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then AMPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+1.49%
AMPH - COLL
43%
Loosely correlated
+1.36%
AMRX - COLL
36%
Loosely correlated
+0.23%
VTRS - COLL
34%
Loosely correlated
+1.83%
PAHC - COLL
34%
Loosely correlated
+0.94%
SNDL - COLL
33%
Loosely correlated
-0.56%
More

Groups containing COLL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+1.49%
Pharmaceuticals: Generic
industry (212 stocks)
37%
Loosely correlated
+0.28%